DalsnaFinance › IPOs › Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc. completed its initial public offering on NASDAQ on May 1, 2026, pricing at $18.00 a share.
| Ticker | COAG |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 1, 2026 |
| Offering price | $18.00 |
| Shares offered | 16,750,000 |
| Total raised | $302M |
IPO data is compiled from SEC filings. This page is general information, not investment advice.